Barclays’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Buy |
82,087
+15,135
| +23% | +$348K | ﹤0.01% | 2272 |
|
|
2025
Q1 | $1.94M | Sell |
66,952
-17,838
| -21% | -$517K | ﹤0.01% | 2050 |
|
|
2024
Q4 | $3.15M | Buy |
84,790
+10,334
| +14% | +$384K | ﹤0.01% | 1916 |
|
|
2024
Q3 | $3.61M | Buy |
74,456
+25,878
| +53% | +$1.26M | ﹤0.01% | 1752 |
|
|
2024
Q2 | $1.94M | Sell |
48,578
-22,254
| -31% | -$890K | ﹤0.01% | 1731 |
|
|
2024
Q1 | $3.11M | Buy |
70,832
+7,590
| +12% | +$333K | ﹤0.01% | 1637 |
|
|
2023
Q4 | $3.91M | Buy |
63,242
+39,449
| +166% | +$2.44M | ﹤0.01% | 1681 |
|
|
2023
Q3 | $1.09M | Sell |
23,793
-6,464
| -21% | -$297K | ﹤0.01% | 2030 |
|
|
2023
Q2 | $1.74M | Sell |
30,257
-11,057
| -27% | -$635K | ﹤0.01% | 1823 |
|
|
2023
Q1 | $1.55M | Sell |
41,314
-21,616
| -34% | -$810K | ﹤0.01% | 1829 |
|
|
2022
Q4 | $1.76M | Buy |
62,930
+7,426
| +13% | +$208K | ﹤0.01% | 1716 |
|
|
2022
Q3 | $1.56M | Sell |
55,504
-8,614
| -13% | -$242K | ﹤0.01% | 1818 |
|
|
2022
Q2 | $2.23M | Buy |
64,118
+11,773
| +22% | +$410K | ﹤0.01% | 1522 |
|
|
2022
Q1 | $1.88M | Sell |
52,345
-21,085
| -29% | -$757K | ﹤0.01% | 1818 |
|
|
2021
Q4 | $1.71M | Buy |
73,430
+9,613
| +15% | +$224K | ﹤0.01% | 1896 |
|
|
2021
Q3 | $1.21M | Buy |
63,817
+18,131
| +40% | +$344K | ﹤0.01% | 2139 |
|
|
2021
Q2 | $921K | Sell |
45,686
-29,431
| -39% | -$593K | ﹤0.01% | 2157 |
|
|
2021
Q1 | $1.38M | Buy |
75,117
+2,229
| +3% | +$40.9K | ﹤0.01% | 2120 |
|
|
2020
Q4 | $1.47M | Buy |
72,888
+4,109
| +6% | +$82.7K | ﹤0.01% | 1765 |
|
|
2020
Q3 | $1.29M | Buy |
68,779
+12,711
| +23% | +$238K | ﹤0.01% | 1770 |
|
|
2020
Q2 | $1.26M | Buy |
56,068
+12,793
| +30% | +$287K | ﹤0.01% | 1782 |
|
|
2020
Q1 | $642K | Sell |
43,275
-11,686
| -21% | -$173K | ﹤0.01% | 1993 |
|
|
2019
Q4 | $1.06M | Buy |
54,961
+17,564
| +47% | +$339K | ﹤0.01% | 2267 |
|
|
2019
Q3 | $742K | Sell |
37,397
-4,004
| -10% | -$79.4K | ﹤0.01% | 2420 |
|
|
2019
Q2 | $873K | Buy |
41,401
+10,352
| +33% | +$218K | ﹤0.01% | 2424 |
|
|
2019
Q1 | $634K | Buy |
31,049
+17,733
| +133% | +$362K | ﹤0.01% | 2469 |
|
|
2018
Q4 | $265K | Sell |
13,316
-24,796
| -65% | -$493K | ﹤0.01% | 2603 |
|
|
2018
Q3 | $733K | Buy |
38,112
+19,823
| +108% | +$381K | ﹤0.01% | 2440 |
|
|
2018
Q2 | $278K | Buy |
18,289
+759
| +4% | +$11.5K | ﹤0.01% | 2575 |
|
|
2018
Q1 | $328K | Buy |
17,530
+11,746
| +203% | +$220K | ﹤0.01% | 2557 |
|
|
2017
Q4 | $112K | Buy |
5,784
+4,942
| +587% | +$95.7K | ﹤0.01% | 2948 |
|
|
2017
Q3 | $15K | Sell |
842
-5,026
| -86% | -$89.5K | ﹤0.01% | 3300 |
|
|
2017
Q2 | $105K | Buy |
5,868
+1,871
| +47% | +$33.5K | ﹤0.01% | 2742 |
|
|
2017
Q1 | $59K | Sell |
3,997
-83,695
| -95% | -$1.24M | ﹤0.01% | 3039 |
|
|
2016
Q4 | $1.62M | Buy |
87,692
+47,590
| +119% | +$876K | ﹤0.01% | 1252 |
|
|
2016
Q3 | $760K | Buy |
40,102
+34,249
| +585% | +$649K | ﹤0.01% | 1551 |
|
|
2016
Q2 | $94K | Buy |
5,853
+3,146
| +116% | +$50.5K | ﹤0.01% | 2361 |
|
|
2016
Q1 | $33K | Buy |
2,707
+1,997
| +281% | +$24.3K | ﹤0.01% | 2652 |
|
|
2015
Q4 | $9K | Sell |
710
-13,442
| -95% | -$170K | ﹤0.01% | 2829 |
|
|
2015
Q3 | $156K | Buy |
14,152
+13,452
| +1,922% | +$148K | ﹤0.01% | 2214 |
|
|
2015
Q2 | $12K | Sell |
700
-84
| -11% | -$1.44K | ﹤0.01% | 3211 |
|
|
2015
Q1 | $11K | Buy |
784
+58
| +8% | +$814 | ﹤0.01% | 3347 |
|
|
2014
Q4 | $8K | Buy |
+726
| New | +$8K | ﹤0.01% | 3818 |
|